Array Biopharma (ARRY) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $8.54 +6.75%
EPS Growth %: -48.0%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -48.0%
Financial Fact:
Weighted average shares outstanding - diluted (in shares): 145.1M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $26.67 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FirstCash to acquire UK pawn operator Ramsdens for £206 million
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
